These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4653136)

  • 1. [Antineuraminidase antibodies in influenza infection and vaccination with inactivated vaccines].
    Profeta ML; Zanetti A; Bergamini F
    Boll Ist Sieroter Milan; 1972; 51(3):190-9. PubMed ID: 4653136
    [No Abstract]   [Full Text] [Related]  

  • 2. [Course of antibodies in men after vaccination with the inactivated influenca vaccine Alorbat (author's transl)].
    Pressler K; Schenk KD
    Med Klin; 1978 Sep; 73(38):1321-6. PubMed ID: 703655
    [No Abstract]   [Full Text] [Related]  

  • 3. Antineuraminidase antibody response of man to influenza virus neuraminidase N2: results obtained with an improved hemagglutination inhibition technique and an enzyme inhibition test.
    Hennessy AV; Minuse E; Davenport FM
    J Immunol; 1972 Aug; 109(2):213-6. PubMed ID: 5047368
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 5. [Research on the immunity against influenza in the population of Milan in the fall of 1972. Distribution of h.i.a. (hemagglutination inhibition antibodies) against A-Hong Kong-68 and A-England-42-72 viruses and the immunizing effectiveness of current vaccines].
    Profeta ML; Bergamini F
    Boll Ist Sieroter Milan; 1973; 52(1):25-31. PubMed ID: 4714450
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complement fixation, hemagglutination inhibition and neuraminidase inhibition reactions in the seroepidemiologic evaluation of an influenza A epidemic].
    Volpi A; Ragona G; Gentile R; Cervelli G; De Felici A; Muzzi A
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):287-91. PubMed ID: 1016581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified viral neuraminidase vaccine to control influenza.
    Arora DJ
    Can Med Assoc J; 1979 Dec; 121(12):1575-9. PubMed ID: 394829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization antibody response to A2 Hong Kong influenza vaccine and its duration in school age children.
    Hosai H; Omura S; Maeda A; Kunita N
    Biken J; 1970 Dec; 13(4):277-87. PubMed ID: 5510350
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunity status of the Milanese population towards B-Hong Kong-8-73, the new B type strain and study of the immunizing activity of the old composition vaccine].
    Profeta ML; Zanetti AR; Bergamini F
    Boll Ist Sieroter Milan; 1973; 52(5):429-35. PubMed ID: 4788200
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of antineuraminidase antibodies in the human immunological response to the administration of live type A influenza vaccines].
    Naĭkhin AN; Topuriia NV; Denisov GM
    Mikrobiol Zh (1978); 1980; 42(5):642-5. PubMed ID: 7432210
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G; Greenbaum E; Zakay-Rones Z
    Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of antineuraminidase antibody in immunity to influenza virus infection.
    Schulman JL
    Bull World Health Organ; 1969; 41(3):647-50. PubMed ID: 5309490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serological response to anti-influenza booster vaccination in a group of aged subjects].
    Crovari-Cuneo P; De Flora S; Vannucci A; Badolati G
    G Ig Med Prev; 1967; 8(5):623-30. PubMed ID: 5605876
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of antineuraminidase antibodies in protection against influenza].
    Aymard M; Gerentes L; Kessler N
    Bull Acad Natl Med; 1998; 182(8):1723-36; discussion 1736-7. PubMed ID: 10188318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of immunity in influenza].
    Zilişteanu E; Creţescu L; Maţepiuc
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1975; 20(3):137-46. PubMed ID: 128102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody response to anti-influenza vaccination with A2-Hong Kong-68 and B-Roma-1-67 bivalent vaccine].
    Dal Fabbro G; Valletta G; Frugoni G; Ricciardi-Tenore N
    Minerva Med; 1972; 63(38):2167-71. PubMed ID: 4664783
    [No Abstract]   [Full Text] [Related]  

  • 18. Influenza antibody response following aerosal administration of inactivated virus.
    Waldman RH; Wood SH; Torres EJ; Small PA
    Am J Epidemiol; 1970 Jun; 91(6):574-85. PubMed ID: 5445644
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenicity in medical students of current programs for influenza vaccination.
    Berlin BS
    J Am Coll Health Assoc; 1972 Apr; 20(4):241-5. PubMed ID: 5017983
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody formation after vaccination with adsorbed and non-adsorbed A/New Jersey/8/76 influenza vaccines.
    Schenk KD; Pressler K; Sarateanu DE; Peukert M; Ehrengut W; Schnitker J
    Pharmatherapeutica; 1982; 3(3):201-8. PubMed ID: 7134228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.